These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 10408185

  • 1. [Incidence of immunogenic hyperthyroidism after radioiodine therapy of focal thyroid gland autonomy. Results of a multicenter study].
    Weiss M, Görges R, Hirsch C, Bader J, Tatsch K, Hahn K.
    Med Klin (Munich); 1999 May 15; 94(5):239-44. PubMed ID: 10408185
    [Abstract] [Full Text] [Related]

  • 2. [Radioiodine therapy of functional autonomy of the thyroid gland. Treatment results in view of pretreatment scintigraphic diagnosis and early response of triiodothyronine levels to treatment].
    Langhammer HR, Laubenbacher C, Hirsch C, Klingele C, Spyra JL, Senekowitsch-Schmidtke R, Schwaiger M.
    Med Klin (Munich); 1999 Aug 15; 94(8):415-24. PubMed ID: 10495620
    [Abstract] [Full Text] [Related]

  • 3. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
    Schmidt M, Gorbauch E, Dietlein M, Faust M, Stützer H, Eschner W, Theissen P, Schicha H.
    Thyroid; 2006 Mar 15; 16(3):281-8. PubMed ID: 16571091
    [Abstract] [Full Text] [Related]

  • 4. [Occurrence of immune hyperthyroidism after radioiodine therapy of autonomous goiter].
    Hirsch C, Spyra JL, Langhammer HR, Laubenbacher C, Senekowitsch-Schmidtke R, Schwaiger M.
    Med Klin (Munich); 1997 Mar 15; 92(3):130-7. PubMed ID: 9173203
    [Abstract] [Full Text] [Related]

  • 5. [Immunogenic hyperthyroidism following radioiodine ablation of a focal autonomy].
    Boddenberg B, Voth E, Schicha H.
    Nuklearmedizin; 1993 Feb 15; 32(1):18-22. PubMed ID: 8464755
    [Abstract] [Full Text] [Related]

  • 6. Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay.
    Dunkelmann S, Wolf R, Koch A, Kittner C, Groth P, Schuemichen C.
    Eur J Nucl Med Mol Imaging; 2004 Oct 15; 31(10):1428-34. PubMed ID: 15221291
    [Abstract] [Full Text] [Related]

  • 7. Association of the risk of development of hypothyroidism after iodine 131 treatment with the pretreatment pattern of sodium pertechnetate Tc 99m uptake in the thyroid gland in cats with hyperthyroidism: 165 cases (1990-2002).
    Nykamp SG, Dykes NL, Zarfoss MK, Scarlett JM.
    J Am Vet Med Assoc; 2005 May 15; 226(10):1671-5. PubMed ID: 15906566
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Radiometabolic therapy of the autonomous thyroid nodule].
    Mariotti S, Caturegli P, Barbesino G, Ceccarelli C, Lippi F, Marinò M, Manetti L, Martino E, Pinchera A.
    Minerva Endocrinol; 1993 Dec 15; 18(4):155-63. PubMed ID: 8190055
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Radioiodine therapy of thyroid autonomy.
    Reiners C, Schneider P.
    Eur J Nucl Med Mol Imaging; 2002 Aug 15; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [Abstract] [Full Text] [Related]

  • 12. Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy.
    Reinhardt M, Emrich D, Krause T, Bräutigam P, Nitzsche E, Blattmann H, Schümichen C, Moser E.
    Eur J Endocrinol; 1995 May 15; 132(5):550-6. PubMed ID: 7749494
    [Abstract] [Full Text] [Related]

  • 13. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.
    Ceccarelli C, Bencivelli W, Vitti P, Grasso L, Pinchera A.
    Clin Endocrinol (Oxf); 2005 Mar 15; 62(3):331-5. PubMed ID: 15730415
    [Abstract] [Full Text] [Related]

  • 14. [Radioiodine therapy for combined disseminated and nodular thyroid autonomy. Results after using a correction term for the disseminated part].
    Vogt H, Wengenmair H, Kopp J, Dorn R, Otto I, Sciuk J.
    Nuklearmedizin; 2006 Mar 15; 45(3):101-4. PubMed ID: 16710504
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975-1996.
    Burch HB, Shakir F, Fitzsimmons TR, Jaques DP, Shriver CD.
    Thyroid; 1998 Oct 15; 8(10):871-80. PubMed ID: 9827653
    [Abstract] [Full Text] [Related]

  • 16. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound.
    Meller J, Becker W.
    Eur J Nucl Med Mol Imaging; 2002 Aug 15; 29 Suppl 2():S425-38. PubMed ID: 12192542
    [Abstract] [Full Text] [Related]

  • 17. Autoimmune Thyroid Diseases.
    Petranović Ovčariček P, Görges R, Giovanella L.
    Semin Nucl Med; 2024 Mar 15; 54(2):219-236. PubMed ID: 38044176
    [Abstract] [Full Text] [Related]

  • 18. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
    Reinhardt MJ, Joe A, von Mallek D, Zimmerlin M, Manka-Waluch A, Palmedo H, Krause TM.
    Eur J Nucl Med Mol Imaging; 2002 Apr 15; 29(4):480-5. PubMed ID: 11914885
    [Abstract] [Full Text] [Related]

  • 19. Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy.
    Meller J, Becker W.
    Q J Nucl Med; 1999 Sep 15; 43(3):179-87. PubMed ID: 10568133
    [Abstract] [Full Text] [Related]

  • 20. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
    Ruchała M, Sowiński J, Dolata M, Junik R, Gembicki M, Skiba A.
    Nucl Med Rev Cent East Eur; 2005 Sep 15; 8(1):28-32. PubMed ID: 15977144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.